

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 9.01586985 |
| 2 | protein refolding (GO:0042026) | 8.55803829 |
| 3 | mRNA transcription (GO:0009299) | 7.99285759 |
| 4 | negative regulation of cell fate specification (GO:0009996) | 7.93053858 |
| 5 | regulation of inclusion body assembly (GO:0090083) | 7.51386170 |
| 6 | renal system development (GO:0072001) | 7.16509446 |
| 7 | embryonic heart tube development (GO:0035050) | 6.98234358 |
| 8 | endothelial tube morphogenesis (GO:0061154) | 6.84239179 |
| 9 | morphogenesis of an endothelium (GO:0003159) | 6.84239179 |
| 10 | negative regulation of cell fate commitment (GO:0010454) | 6.71363857 |
| 11 | endoderm formation (GO:0001706) | 6.68572443 |
| 12 | synaptic transmission, cholinergic (GO:0007271) | 6.66263638 |
| 13 | embryonic foregut morphogenesis (GO:0048617) | 6.20071214 |
| 14 | regulation of transcription involved in cell fate commitment (GO:0060850) | 6.13247867 |
| 15 | positive regulation of skeletal muscle tissue development (GO:0048643) | 6.03577104 |
| 16 | cell migration involved in gastrulation (GO:0042074) | 5.87148339 |
| 17 | regulation of mesoderm development (GO:2000380) | 5.73955431 |
| 18 | organ formation (GO:0048645) | 5.45079606 |
| 19 | endothelium development (GO:0003158) | 5.21729415 |
| 20 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 5.09132078 |
| 21 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.93703799 |
| 22 | axon ensheathment in central nervous system (GO:0032291) | 4.57907031 |
| 23 | central nervous system myelination (GO:0022010) | 4.57907031 |
| 24 | axonemal dynein complex assembly (GO:0070286) | 4.57236591 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.44030528 |
| 26 | digestive tract morphogenesis (GO:0048546) | 4.41322794 |
| 27 | opioid receptor signaling pathway (GO:0038003) | 4.29920172 |
| 28 | endothelial cell differentiation (GO:0045446) | 4.28079795 |
| 29 | negative regulation of protein autophosphorylation (GO:0031953) | 4.15736223 |
| 30 | cilium movement (GO:0003341) | 4.13427240 |
| 31 | regulation of cell fate specification (GO:0042659) | 4.07788999 |
| 32 | notochord development (GO:0030903) | 4.03377662 |
| 33 | Notch signaling involved in heart development (GO:0061314) | 4.01725417 |
| 34 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.97624688 |
| 35 | type B pancreatic cell development (GO:0003323) | 3.97322638 |
| 36 | presynaptic membrane assembly (GO:0097105) | 3.94156514 |
| 37 | negative regulation of embryonic development (GO:0045992) | 3.84497599 |
| 38 | microglial cell activation (GO:0001774) | 3.79938178 |
| 39 | neuron fate determination (GO:0048664) | 3.69809277 |
| 40 | pattern specification involved in kidney development (GO:0061004) | 3.62209733 |
| 41 | radial glial cell differentiation (GO:0060019) | 3.56942983 |
| 42 | cellular response to interferon-beta (GO:0035458) | 3.52789192 |
| 43 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.47717696 |
| 44 | glucosamine-containing compound catabolic process (GO:1901072) | 3.42846744 |
| 45 | negative regulation of glial cell differentiation (GO:0045686) | 3.36867687 |
| 46 | regulation of podosome assembly (GO:0071801) | 3.33680482 |
| 47 | outflow tract morphogenesis (GO:0003151) | 3.30958669 |
| 48 | SMAD protein signal transduction (GO:0060395) | 3.25645858 |
| 49 | ubiquinone biosynthetic process (GO:0006744) | 3.25245983 |
| 50 | ubiquinone metabolic process (GO:0006743) | 3.24784113 |
| 51 | negative regulation by host of viral transcription (GO:0043922) | 3.23242932 |
| 52 | cellular response to heat (GO:0034605) | 3.20013602 |
| 53 | L-fucose catabolic process (GO:0042355) | 3.19510980 |
| 54 | fucose catabolic process (GO:0019317) | 3.19510980 |
| 55 | L-fucose metabolic process (GO:0042354) | 3.19510980 |
| 56 | presynaptic membrane organization (GO:0097090) | 3.18355063 |
| 57 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.14311908 |
| 58 | Notch receptor processing (GO:0007220) | 3.14015919 |
| 59 | positive regulation by host of viral transcription (GO:0043923) | 3.13709432 |
| 60 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.13223251 |
| 61 | heart valve formation (GO:0003188) | 3.12562580 |
| 62 | regulation of cell fate commitment (GO:0010453) | 3.12409538 |
| 63 | response to gravity (GO:0009629) | 3.12153193 |
| 64 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.10394407 |
| 65 | limb development (GO:0060173) | 3.08489506 |
| 66 | appendage development (GO:0048736) | 3.08489506 |
| 67 | regulation of erythrocyte differentiation (GO:0045646) | 3.08001421 |
| 68 | epithelial cilium movement (GO:0003351) | 3.02930332 |
| 69 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.01516368 |
| 70 | cranial nerve development (GO:0021545) | 3.01286384 |
| 71 | neuronal stem cell maintenance (GO:0097150) | 2.95427153 |
| 72 | regulation of gastrulation (GO:0010470) | 2.91826826 |
| 73 | hindlimb morphogenesis (GO:0035137) | 2.86029009 |
| 74 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.85083088 |
| 75 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.76913650 |
| 76 | pancreas development (GO:0031016) | 2.76737253 |
| 77 | S-adenosylmethionine metabolic process (GO:0046500) | 2.74957289 |
| 78 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.74385999 |
| 79 | telencephalon development (GO:0021537) | 2.73128168 |
| 80 | asymmetric protein localization (GO:0008105) | 2.72886167 |
| 81 | positive regulation of glial cell differentiation (GO:0045687) | 2.71919705 |
| 82 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.69473598 |
| 83 | lymphangiogenesis (GO:0001946) | 2.68174423 |
| 84 | neuron cell-cell adhesion (GO:0007158) | 2.67871216 |
| 85 | neurotransmitter catabolic process (GO:0042135) | 2.67312036 |
| 86 | somite development (GO:0061053) | 2.65390344 |
| 87 | positive regulation of Notch signaling pathway (GO:0045747) | 2.64602826 |
| 88 | forelimb morphogenesis (GO:0035136) | 2.63779543 |
| 89 | heart trabecula morphogenesis (GO:0061384) | 2.61974273 |
| 90 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.61763600 |
| 91 | quinone biosynthetic process (GO:1901663) | 2.61163409 |
| 92 | regulation of monocyte differentiation (GO:0045655) | 2.60707095 |
| 93 | cell proliferation involved in kidney development (GO:0072111) | 2.60276583 |
| 94 | smoothened signaling pathway (GO:0007224) | 2.60251632 |
| 95 | tongue development (GO:0043586) | 2.60028435 |
| 96 | oligodendrocyte differentiation (GO:0048709) | 2.59330504 |
| 97 | inner ear receptor stereocilium organization (GO:0060122) | 2.58344761 |
| 98 | sequestering of actin monomers (GO:0042989) | 2.57454470 |
| 99 | negative regulation of inclusion body assembly (GO:0090084) | 12.7567699 |
| 100 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 10.0485745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.75734825 |
| 2 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.85357828 |
| 3 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.82112990 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.61890791 |
| 5 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55029316 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51140987 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.44376123 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.40922847 |
| 9 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.39194865 |
| 10 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.30894466 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.30272016 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.29100943 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.27514716 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27164969 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.26058609 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11604198 |
| 17 | EWS_26573619_Chip-Seq_HEK293_Human | 2.08134953 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07384694 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07384694 |
| 20 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.06359764 |
| 21 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.00772650 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.96429003 |
| 23 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.96429003 |
| 24 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.96429003 |
| 25 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.96039152 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.95977431 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95974531 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.95938612 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.95392266 |
| 30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.93749498 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88965720 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84306377 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.83705124 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82340769 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.75445529 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.71704603 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70557825 |
| 38 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.63485746 |
| 39 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60276846 |
| 40 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.57127949 |
| 41 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.52844261 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51279118 |
| 43 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.48946259 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48687517 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48278234 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48252402 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48235502 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45558751 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44142547 |
| 50 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.39777628 |
| 51 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.38575415 |
| 52 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35843547 |
| 53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.35381079 |
| 54 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35381079 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34990698 |
| 56 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.33356983 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31003568 |
| 58 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30139377 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28949401 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.26470963 |
| 61 | RXR_22108803_ChIP-Seq_LS180_Human | 1.26344646 |
| 62 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24181670 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21956614 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19748831 |
| 65 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17065367 |
| 66 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16450366 |
| 67 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16450366 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16078704 |
| 69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16029012 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.15582614 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14664337 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14483442 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13075427 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12424813 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10482332 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08645356 |
| 77 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.07748380 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06207820 |
| 79 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05947324 |
| 80 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05947324 |
| 81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05943802 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05939905 |
| 83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05633569 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05489110 |
| 85 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04983170 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03599180 |
| 87 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01387232 |
| 88 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00741344 |
| 89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98095431 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97848579 |
| 91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.97655095 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94891319 |
| 93 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94762867 |
| 94 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94548410 |
| 95 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94372032 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94043774 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93759119 |
| 98 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.93428943 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92733951 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92012301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004233_abnormal_muscle_weight | 7.24124212 |
| 2 | MP0002928_abnormal_bile_duct | 6.31896416 |
| 3 | MP0005084_abnormal_gallbladder_morpholo | 6.30225285 |
| 4 | MP0003136_yellow_coat_color | 5.19972377 |
| 5 | MP0008007_abnormal_cellular_replicative | 3.99395675 |
| 6 | MP0003943_abnormal_hepatobiliary_system | 3.03846154 |
| 7 | MP0002653_abnormal_ependyma_morphology | 3.02366621 |
| 8 | MP0008058_abnormal_DNA_repair | 2.80280239 |
| 9 | MP0000343_altered_response_to | 2.35854723 |
| 10 | MP0000465_gastrointestinal_hemorrhage | 2.21952604 |
| 11 | MP0002249_abnormal_larynx_morphology | 2.03100007 |
| 12 | MP0002269_muscular_atrophy | 1.67413694 |
| 13 | MP0004142_abnormal_muscle_tone | 1.63104186 |
| 14 | MP0010368_abnormal_lymphatic_system | 1.62272622 |
| 15 | MP0009250_abnormal_appendicular_skeleto | 1.58730478 |
| 16 | MP0001968_abnormal_touch/_nociception | 1.55762147 |
| 17 | MP0003119_abnormal_digestive_system | 1.50195974 |
| 18 | MP0004885_abnormal_endolymph | 1.46891423 |
| 19 | MP0002736_abnormal_nociception_after | 1.43401423 |
| 20 | MP0001986_abnormal_taste_sensitivity | 1.39404585 |
| 21 | MP0001270_distended_abdomen | 1.39294787 |
| 22 | MP0001958_emphysema | 1.37624542 |
| 23 | MP0001944_abnormal_pancreas_morphology | 1.36028464 |
| 24 | MP0001485_abnormal_pinna_reflex | 1.26571471 |
| 25 | MP0003283_abnormal_digestive_organ | 1.25449453 |
| 26 | MP0002233_abnormal_nose_morphology | 1.22149725 |
| 27 | MP0004742_abnormal_vestibular_system | 1.22017966 |
| 28 | MP0001286_abnormal_eye_development | 1.21110730 |
| 29 | MP0004272_abnormal_basement_membrane | 1.20996711 |
| 30 | MP0002272_abnormal_nervous_system | 1.19855446 |
| 31 | MP0009672_abnormal_birth_weight | 1.15958601 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.15804390 |
| 33 | MP0002697_abnormal_eye_size | 1.15106092 |
| 34 | MP0009379_abnormal_foot_pigmentation | 1.11423365 |
| 35 | MP0001299_abnormal_eye_distance/ | 1.10972188 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.10644089 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.08938683 |
| 38 | MP0001905_abnormal_dopamine_level | 1.08455651 |
| 39 | MP0005448_abnormal_energy_balance | 1.07553782 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.07144131 |
| 41 | MP0003878_abnormal_ear_physiology | 1.07144131 |
| 42 | MP0010094_abnormal_chromosome_stability | 1.04470192 |
| 43 | MP0009745_abnormal_behavioral_response | 1.03868000 |
| 44 | MP0000026_abnormal_inner_ear | 1.01768290 |
| 45 | MP0002282_abnormal_trachea_morphology | 1.01682587 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01478204 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 0.99142694 |
| 48 | MP0001293_anophthalmia | 0.91030631 |
| 49 | MP0002064_seizures | 0.90945239 |
| 50 | MP0005503_abnormal_tendon_morphology | 0.88857109 |
| 51 | MP0000762_abnormal_tongue_morphology | 0.87658526 |
| 52 | MP0001486_abnormal_startle_reflex | 0.87253895 |
| 53 | MP0003880_abnormal_central_pattern | 0.86755228 |
| 54 | MP0000778_abnormal_nervous_system | 0.85899374 |
| 55 | MP0002735_abnormal_chemical_nociception | 0.85537470 |
| 56 | MP0003755_abnormal_palate_morphology | 0.83535182 |
| 57 | MP0000631_abnormal_neuroendocrine_gland | 0.83173858 |
| 58 | MP0002067_abnormal_sensory_capabilities | 0.80701300 |
| 59 | MP0000685_abnormal_immune_system | 0.78953953 |
| 60 | MP0005595_abnormal_vascular_smooth | 0.78923281 |
| 61 | MP0001501_abnormal_sleep_pattern | 0.77892386 |
| 62 | MP0009764_decreased_sensitivity_to | 0.76356121 |
| 63 | MP0001502_abnormal_circadian_rhythm | 0.75402407 |
| 64 | MP0005391_vision/eye_phenotype | 0.73544495 |
| 65 | MP0008872_abnormal_physiological_respon | 0.73509281 |
| 66 | MP0001963_abnormal_hearing_physiology | 0.72138630 |
| 67 | MP0000372_irregular_coat_pigmentation | 0.71701453 |
| 68 | MP0009703_decreased_birth_body | 0.70493244 |
| 69 | MP0001340_abnormal_eyelid_morphology | 0.69172445 |
| 70 | MP0002752_abnormal_somatic_nervous | 0.68539410 |
| 71 | MP0000249_abnormal_blood_vessel | 0.66668562 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.64225707 |
| 73 | MP0000955_abnormal_spinal_cord | 0.62824229 |
| 74 | MP0005253_abnormal_eye_physiology | 0.62476486 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.61331570 |
| 76 | MP0001529_abnormal_vocalization | 0.60210555 |
| 77 | MP0001851_eye_inflammation | 0.59669994 |
| 78 | MP0003186_abnormal_redox_activity | 0.59484708 |
| 79 | MP0002092_abnormal_eye_morphology | 0.58178269 |
| 80 | MP0003724_increased_susceptibility_to | 0.57260510 |
| 81 | MP0005187_abnormal_penis_morphology | 0.56501308 |
| 82 | MP0002572_abnormal_emotion/affect_behav | 0.56122940 |
| 83 | MP0004133_heterotaxia | 0.55790771 |
| 84 | MP0000049_abnormal_middle_ear | 0.55496534 |
| 85 | MP0003632_abnormal_nervous_system | 0.54774234 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.54529811 |
| 87 | MP0000534_abnormal_ureter_morphology | 0.53242112 |
| 88 | MP0001984_abnormal_olfaction | 0.51872498 |
| 89 | MP0001324_abnormal_eye_pigmentation | 0.51573998 |
| 90 | MP0005195_abnormal_posterior_eye | 0.51018970 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.50219124 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.48804281 |
| 93 | MP0000516_abnormal_urinary_system | 0.48804281 |
| 94 | MP0003635_abnormal_synaptic_transmissio | 0.48804196 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 0.48398904 |
| 96 | MP0005646_abnormal_pituitary_gland | 0.48335767 |
| 97 | MP0003879_abnormal_hair_cell | 0.48088766 |
| 98 | MP0005620_abnormal_muscle_contractility | 0.47063971 |
| 99 | MP0002148_abnormal_hypersensitivity_rea | 0.46676367 |
| 100 | MP0002734_abnormal_mechanical_nocicepti | 0.46435744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber atrophy (HP:0100295) | 9.09829904 |
| 2 | Fatigable weakness (HP:0003473) | 6.73933131 |
| 3 | Abnormality of the neuromuscular junction (HP:0003398) | 6.73933131 |
| 4 | Nonprogressive disorder (HP:0003680) | 6.28298982 |
| 5 | Poor suck (HP:0002033) | 6.20334443 |
| 6 | Weak cry (HP:0001612) | 5.73806947 |
| 7 | Hydroureter (HP:0000072) | 5.71045977 |
| 8 | Decreased muscle mass (HP:0003199) | 5.26543637 |
| 9 | Easy fatigability (HP:0003388) | 4.78277499 |
| 10 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 4.56810244 |
| 11 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.46234380 |
| 12 | Fibular hypoplasia (HP:0003038) | 4.36077158 |
| 13 | Abnormality of the columella (HP:0009929) | 4.32570860 |
| 14 | Abnormal ciliary motility (HP:0012262) | 4.07930946 |
| 15 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.06365036 |
| 16 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 4.06150797 |
| 17 | Bulbar palsy (HP:0001283) | 4.01554484 |
| 18 | Generalized muscle weakness (HP:0003324) | 3.99310264 |
| 19 | Abnormality of the frontal sinuses (HP:0002687) | 3.90673699 |
| 20 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 3.73414675 |
| 21 | Median cleft lip (HP:0000161) | 3.70515576 |
| 22 | True hermaphroditism (HP:0010459) | 3.66918789 |
| 23 | Rhinitis (HP:0012384) | 3.55591861 |
| 24 | Esophageal atresia (HP:0002032) | 3.53235292 |
| 25 | Anophthalmia (HP:0000528) | 3.34826910 |
| 26 | High anterior hairline (HP:0009890) | 3.31781519 |
| 27 | Oligodactyly (hands) (HP:0001180) | 3.24616260 |
| 28 | Abnormality of the incisor (HP:0000676) | 3.03566566 |
| 29 | Gonadotropin excess (HP:0000837) | 2.92956038 |
| 30 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.79623511 |
| 31 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.79623511 |
| 32 | Gastrointestinal atresia (HP:0002589) | 2.69737780 |
| 33 | Gowers sign (HP:0003391) | 2.54223161 |
| 34 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.48699202 |
| 35 | Short tibia (HP:0005736) | 2.45689148 |
| 36 | Abnormal number of incisors (HP:0011064) | 2.42184670 |
| 37 | Chronic bronchitis (HP:0004469) | 2.41292865 |
| 38 | Missing ribs (HP:0000921) | 2.37811756 |
| 39 | Severe muscular hypotonia (HP:0006829) | 2.33894246 |
| 40 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.24594566 |
| 41 | Vertebral hypoplasia (HP:0008417) | 2.24594566 |
| 42 | Rib fusion (HP:0000902) | 2.22898220 |
| 43 | Abnormality of DNA repair (HP:0003254) | 2.21373129 |
| 44 | Depressed nasal tip (HP:0000437) | 2.21268633 |
| 45 | 11 pairs of ribs (HP:0000878) | 2.20999706 |
| 46 | Sclerocornea (HP:0000647) | 2.20620979 |
| 47 | Pancreatic cysts (HP:0001737) | 2.20577632 |
| 48 | Calf muscle hypertrophy (HP:0008981) | 2.15508977 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.15452437 |
| 50 | Chronic sinusitis (HP:0011109) | 2.12837697 |
| 51 | Septo-optic dysplasia (HP:0100842) | 2.06878177 |
| 52 | Abnormality of the fibula (HP:0002991) | 2.06333507 |
| 53 | Menstrual irregularities (HP:0000858) | 2.04077026 |
| 54 | Type 2 muscle fiber atrophy (HP:0003554) | 10.3175996 |
| 55 | Absent/shortened dynein arms (HP:0200106) | 1.99311974 |
| 56 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99311974 |
| 57 | Split foot (HP:0001839) | 1.97813076 |
| 58 | Bronchiectasis (HP:0002110) | 1.94495087 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 1.92810284 |
| 60 | Cystic liver disease (HP:0006706) | 1.91803351 |
| 61 | Postaxial hand polydactyly (HP:0001162) | 1.90946085 |
| 62 | Type II lissencephaly (HP:0007260) | 1.90545739 |
| 63 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.88316038 |
| 64 | Oligodactyly (HP:0012165) | 1.87595883 |
| 65 | Abnormal number of erythroid precursors (HP:0012131) | 1.87511677 |
| 66 | Abnormality of the diencephalon (HP:0010662) | 1.83099945 |
| 67 | Decreased central vision (HP:0007663) | 1.82199189 |
| 68 | Ulnar claw (HP:0001178) | 1.81427017 |
| 69 | Abnormal sex determination (HP:0012244) | 1.81147168 |
| 70 | Sex reversal (HP:0012245) | 1.81147168 |
| 71 | Infertility (HP:0000789) | 1.78539776 |
| 72 | Abnormality of the 4th metacarpal (HP:0010012) | 1.77688571 |
| 73 | Benign neoplasm of the central nervous system (HP:0100835) | 1.77054664 |
| 74 | Molar tooth sign on MRI (HP:0002419) | 1.75689023 |
| 75 | Abnormality of midbrain morphology (HP:0002418) | 1.75689023 |
| 76 | Abnormality of the nasal mucosa (HP:0000433) | 1.75631160 |
| 77 | Abnormality of the pons (HP:0007361) | 1.74746438 |
| 78 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.73087016 |
| 79 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.72449709 |
| 80 | Tibial bowing (HP:0002982) | 1.70328027 |
| 81 | Postaxial foot polydactyly (HP:0001830) | 1.67010727 |
| 82 | Scotoma (HP:0000575) | 1.66167253 |
| 83 | Hemivertebrae (HP:0002937) | 1.65968459 |
| 84 | Gait imbalance (HP:0002141) | 1.65143079 |
| 85 | Cerebellar dysplasia (HP:0007033) | 1.63021065 |
| 86 | Bilateral microphthalmos (HP:0007633) | 1.62196664 |
| 87 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.60497216 |
| 88 | Poor coordination (HP:0002370) | 1.59660866 |
| 89 | Bone cyst (HP:0012062) | 1.58280875 |
| 90 | Fibular aplasia (HP:0002990) | 1.57256249 |
| 91 | Congenital, generalized hypertrichosis (HP:0004540) | 1.56576171 |
| 92 | Neonatal short-limb short stature (HP:0008921) | 1.53043633 |
| 93 | Nasal polyposis (HP:0100582) | 1.51610201 |
| 94 | Congenital primary aphakia (HP:0007707) | 1.51259315 |
| 95 | Male pseudohermaphroditism (HP:0000037) | 1.48248933 |
| 96 | Occipital encephalocele (HP:0002085) | 1.47414956 |
| 97 | Vertebral fusion (HP:0002948) | 1.46485695 |
| 98 | Maternal diabetes (HP:0009800) | 1.45555966 |
| 99 | Congenital stationary night blindness (HP:0007642) | 1.44559870 |
| 100 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.44306767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 8.39745230 |
| 2 | PNCK | 3.14278961 |
| 3 | VRK1 | 2.50640206 |
| 4 | TAOK3 | 2.12292740 |
| 5 | WEE1 | 2.09274820 |
| 6 | PDK2 | 2.04799606 |
| 7 | TSSK6 | 12.1100905 |
| 8 | TIE1 | 1.77657116 |
| 9 | FRK | 1.55711962 |
| 10 | CDK3 | 1.47974119 |
| 11 | IRAK1 | 1.40402878 |
| 12 | MAPKAPK3 | 1.29413857 |
| 13 | MAPKAPK5 | 1.20890625 |
| 14 | MKNK2 | 1.04491826 |
| 15 | TRIM28 | 0.94702814 |
| 16 | ADRBK2 | 0.94592268 |
| 17 | PLK3 | 0.93689654 |
| 18 | MAP3K4 | 0.90012445 |
| 19 | NME1 | 0.85917820 |
| 20 | TAF1 | 0.85592265 |
| 21 | IRAK2 | 0.84119663 |
| 22 | CASK | 0.81830143 |
| 23 | MAP2K7 | 0.79091809 |
| 24 | GRK1 | 0.74837099 |
| 25 | IRAK4 | 0.72949108 |
| 26 | MKNK1 | 0.70992323 |
| 27 | NEK6 | 0.67359527 |
| 28 | MAPK13 | 0.66274386 |
| 29 | TYRO3 | 0.65298896 |
| 30 | MAP2K2 | 0.63738356 |
| 31 | DMPK | 0.62334610 |
| 32 | EPHA3 | 0.61307835 |
| 33 | PAK2 | 0.59811487 |
| 34 | MAP3K10 | 0.57743538 |
| 35 | BMPR1B | 0.55835936 |
| 36 | BMPR2 | 0.54296793 |
| 37 | PRKD3 | 0.51191986 |
| 38 | EPHB1 | 0.47937018 |
| 39 | PRKCH | 0.47682595 |
| 40 | PRKCG | 0.46894883 |
| 41 | PAK4 | 0.44707625 |
| 42 | RPS6KA5 | 0.43977309 |
| 43 | MAPK7 | 0.43432382 |
| 44 | PINK1 | 0.42898683 |
| 45 | GSK3A | 0.40988747 |
| 46 | IKBKE | 0.40623296 |
| 47 | MAPK12 | 0.39090021 |
| 48 | PRKD1 | 0.38340318 |
| 49 | CDK12 | 0.38104785 |
| 50 | PRKCE | 0.37755813 |
| 51 | DYRK1A | 0.36861781 |
| 52 | NTRK2 | 0.36409807 |
| 53 | BRSK2 | 0.36130522 |
| 54 | DYRK3 | 0.35479767 |
| 55 | ADRBK1 | 0.35332531 |
| 56 | PASK | 0.34079925 |
| 57 | NLK | 0.33365302 |
| 58 | BRD4 | 0.32578768 |
| 59 | PIK3CA | 0.31589453 |
| 60 | RPS6KB2 | 0.29980009 |
| 61 | TGFBR1 | 0.29696001 |
| 62 | RPS6KA4 | 0.29134393 |
| 63 | MARK3 | 0.28977913 |
| 64 | PKN1 | 0.28930714 |
| 65 | CSNK1G1 | 0.27904339 |
| 66 | PRKCI | 0.27094632 |
| 67 | MAP3K7 | 0.26655222 |
| 68 | DYRK2 | 0.24199119 |
| 69 | FGFR3 | 0.24005191 |
| 70 | PRKG1 | 0.21708728 |
| 71 | TLK1 | 0.20890827 |
| 72 | MARK1 | 0.20404219 |
| 73 | ZAK | 0.19017776 |
| 74 | SGK2 | 0.18377754 |
| 75 | OXSR1 | 0.17570550 |
| 76 | RPS6KA1 | 0.16278811 |
| 77 | IKBKB | 0.15729357 |
| 78 | INSRR | 0.15304760 |
| 79 | PLK2 | 0.15292673 |
| 80 | PRKD2 | 0.15232145 |
| 81 | EIF2AK2 | 0.13216910 |
| 82 | LMTK2 | 0.12426916 |
| 83 | MAPK10 | 0.12099563 |
| 84 | MAP3K12 | 0.11203550 |
| 85 | MAPKAPK2 | 0.10493825 |
| 86 | DDR2 | 0.10492312 |
| 87 | CSNK2A2 | 0.08715738 |
| 88 | PHKG2 | 0.08601003 |
| 89 | PHKG1 | 0.08601003 |
| 90 | CSNK1G2 | 0.07384126 |
| 91 | TXK | 0.07000035 |
| 92 | PRKCZ | 0.06789704 |
| 93 | PTK6 | 0.06722736 |
| 94 | PIM2 | 0.06569782 |
| 95 | PRKACA | 0.05650664 |
| 96 | MAPK4 | 0.05576771 |
| 97 | CAMK2A | 0.05567184 |
| 98 | MAP4K1 | 0.04860588 |
| 99 | ERBB3 | 0.04844249 |
| 100 | MAP4K2 | 0.04388285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.46384828 |
| 2 | Legionellosis_Homo sapiens_hsa05134 | 3.23550903 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.00735900 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.96073087 |
| 5 | Prion diseases_Homo sapiens_hsa05020 | 2.96053243 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.61381521 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.49195869 |
| 8 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 2.36002714 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.22407609 |
| 10 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 2.09922246 |
| 11 | Cocaine addiction_Homo sapiens_hsa05030 | 2.05247827 |
| 12 | Asthma_Homo sapiens_hsa05310 | 1.98240387 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.94160472 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.92744141 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.75914631 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.69174637 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.68593862 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59473271 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.57146600 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.50455735 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.47355003 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44168935 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43150218 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38334826 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32845072 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.30168772 |
| 27 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.28816203 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28637891 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28576424 |
| 30 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.24637635 |
| 31 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.17700872 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16775257 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.16141238 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12098196 |
| 35 | Nicotine addiction_Homo sapiens_hsa05033 | 1.09273882 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06265581 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05545118 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.05476000 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05110869 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.01405289 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00959816 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.99390247 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99118819 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98066429 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96902814 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96288098 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96235094 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88668860 |
| 49 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.87721052 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87669881 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 0.87600323 |
| 52 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.86932001 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86149100 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 0.85946904 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 0.82203596 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79156788 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77133368 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76344164 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75885140 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73707744 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.73347442 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72609362 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71790277 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.71760892 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71026167 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.70123551 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68411090 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66134895 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64835599 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60206403 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58056143 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56015984 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55521621 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.54016815 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.53067412 |
| 76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.51057666 |
| 77 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49746739 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49028120 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45520200 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45328590 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44787452 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42655068 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.41885600 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41689797 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40046241 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39374972 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38649011 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34981257 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34072502 |
| 90 | RNA polymerase_Homo sapiens_hsa03020 | 0.33892299 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33402416 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.33256565 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32912368 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32156792 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.31781372 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29700914 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.29011623 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28966846 |
| 99 | Proteasome_Homo sapiens_hsa03050 | 0.28099794 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27794717 |

